11/20/2026 | Press release | Distributed by Public on 11/20/2026 13:30
Denver, Colo. - The therapy provides another option for select patients with high-risk blood cancers, cancers that have returned or those that have resisted treatment.
"TMLI gives us another advanced treatment option for patients facing aggressive blood cancers," said Dr. Tara Gregory, group president of Colorado Blood Cancer Institute.
Read the Colorado Biz article.
Learn more about Dr. Gregory and the team at Colorado Blood Cancer Institute.